2020
DOI: 10.1021/acs.jmedchem.9b01835
|View full text |Cite
|
Sign up to set email alerts
|

Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands

Abstract: 2-Phenylcyclopropylmethylamine (PCPMA) analogues have been reported as selective serotonin 2C agonists. On the basis of the same scaffold, we designed and synthesized a series of bitopic derivatives as dopamine D3R ligands. A number of these new compounds show a high binding affinity for D3R with excellent selectivity. Compound (1R,2R)-22e and its enantiomer (1S,2S)-22e show a comparable binding affinity for the D3R, but the former is a potent D3R agonist, while the latter acts as an antagonist. Molecular dock… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
37
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 17 publications
(37 citation statements)
references
References 29 publications
0
37
0
Order By: Relevance
“…Several groups have generated a variety of synthetic ligands concurring to build similar molecular models including dynamic aspects of DR receptor activation over time. In recombinant systems at least, we witness some amazing activity switches between agonist and “antagonist” properties across different series that require further dynamic considerations ( Tan et al., 2020 ). Destabilization of D3 inactive state(s) and flexibility of the ligands are among the elements that the most recent model available is proposing ( Ferraro et al., 2020 ).…”
Section: Section 3 Dr Ligands and Scz Therapies The New Wave Of Ligmentioning
confidence: 99%
“…Several groups have generated a variety of synthetic ligands concurring to build similar molecular models including dynamic aspects of DR receptor activation over time. In recombinant systems at least, we witness some amazing activity switches between agonist and “antagonist” properties across different series that require further dynamic considerations ( Tan et al., 2020 ). Destabilization of D3 inactive state(s) and flexibility of the ligands are among the elements that the most recent model available is proposing ( Ferraro et al., 2020 ).…”
Section: Section 3 Dr Ligands and Scz Therapies The New Wave Of Ligmentioning
confidence: 99%
“…Bitopicl igandst hat targett he orthosteric site and the receptor vestibule improve selectivity, [11,12] off-rates and signalingb ias, [4,13,14] maintaining bioavailability and brain penetration properties in mice. [15] Othert ype of comparable ligands are designed to simultaneously bind two orthosteric sites of a( homo/hetero) GPCR dimer. [16] These type of ligands have been recently reviewed.…”
mentioning
confidence: 99%
“…Tan et al have exploited the basic 2-phenylcyclopropylmethylamine (PCPMA) scaffold ( 8, 9 ), whose analogues are known 5-HT 2C R agonists ( Cheng et al, 2015 ; Cheng et al, 2016a ; Cheng et al, 2016b ; Zhang et al, 2017 ), to design new bitopic compounds ( Tan et al, 2020 ) ( Supplementary Table S3 ). Here we discuss only a subset of these compounds.…”
Section: Bitopic Ligands To Study Selectivity and Functional Selectiv...mentioning
confidence: 99%
“…For these compounds, only N-alkyl substituted variants have been prepared and the effects of several PPs have been investigated. When examining the racemic compounds, the compound containing 4-pyridylphenyl SP and dichlorophenyl PP ( 20 ) has more than 1000-fold selectivity towards the other DRs, with milder but still significant selectivity in the range of 17 , 18, and 19 ( Tan et al, 2020 ) ( Table 1 ).…”
Section: Bitopic Ligands To Study Selectivity and Functional Selectiv...mentioning
confidence: 99%
See 1 more Smart Citation